December 2017 Issue of The Translational Scientist

Welcome to the December issue of The Translational Scientist! This month, we look at a multiple sclerosis drug being repurposed in the fight against microbial resistance, and cover the opposite of innovation: exnovation. We also sit down with Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute (M4I), Distinguished Professor and Limburg Chair at Maastricht University, The Netherlands. Stay tuned for more of the latest news and views in translational science throughout the month…

Register to download
Register here to download any issue of The Translational Scientist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Translational Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Disease Area Drug discovery

Pain and Vision Gain

| Roisin McGuigan

An analgesic is helping researchers explore new drug targets for sight-threatening diseases
Outside the Lab Cancer

A Deadly Combination

| Roisin McGuigan

Diabetes and obesity often go hand-in-hand, with devastating effects on public health
Disease Area Diagnostics & prognostics

Dark Fields and Diagnostic Disks

| Michael Schubert

New devices for detecting tuberculosis may speed up diagnosis and improve treatment
Outside the Lab Metabolism & Diabetes

Trimming the Fat

| Roisin McGuigan

Could weight management replace medication as the first line treatment for type II diabetes?
Research Field Drug discovery

Believe in RNAi

| Geert Cauwenbergh

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender
Tools & Techniques Cancer

Think Small

| Roisin McGuigan

Nanotechnology helps track down micrometastases missed by MRI
Disease Area Microbiology

From MS to AMR

| Roisin McGuigan

A drug used to treat MS could be repurposed to treat infections in cystic fibrosis patients
Outside the Lab Cardiovascular

Innovation Versus Exnovation

| Roisin McGuigan

Sometimes, medical innovation may need to go backwards to go forwards
Tools & Techniques Analytical science

Collaborating for the Clinical Win

| Joanna Cummings

Sitting Down With... Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute

Other issues of 2017